Analysis of Racial and Socioeconomic Disparities in African American Patients Older Than 40 Years With CKD in the United States
- Diversity and Equity in Kidney Health - I
November 03, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Diversity and Equity in Kidney Health
- 800 Diversity and Equity in Kidney Health
- Ranga, Raghav K., Georgetown University Medical Center, Washington, District of Columbia, United States
Chronic kidney disease and end-stage renal disease are rapidly growing conditions across the world. Due to the ever-increasing burden of the predominant causes of these conditions, hypertension and type 2 diabetes mellitus, it is critical that everyone who develops chronic kidney disease has equal access to care. African Americans in the United States often face an uphill battle due to age-old unwritten policies of systemic discrimination, racism, and barriers that prevent their access to healthcare.
Articles that were written after 2000 were analyzed looking for quantifiable differences in outcomes of African Americans vs. non-Hispanic white people in chronic kidney disease, as well as confounders within the data that could explain the strong correlation between being African American and having a higher probability of death from chronic kidney disease. Articles were obtained from databases such as PubMed, Google Scholar, SciHub, ClinicalKey, eJournals, and MEDLINE. Once this was done, two potential interventions were suggested that could help to address these disparities. The PRISMA Database was used to evaluate study quality.
The articles showed that there was a hazard ratio between 1.30 and 3.00 for African Americans getting all manifestations of kidney disease compared to non-Hispanic White Americans and it showed that one of the main confounding variables affecting racial disparities in kidney care was socioeconomic status. The mean African American household in the United States made more than $30,000 less than non-Hispanic Americans in the year 2019, and this could lead to other barriers.
Race and socioeconomic status both affect kidney disease by a factor of approximately 1.50 times for African Americans as compared to non-Hispanic people. The interventions that were chosen that could impact outcomes increased screenings for variations of polymorphisms of apolipoprotein L1 and sensitivity training for primary care physicians making them aware of the barriers that their African American patients may face in order to provide the most culturally competent care.